Implicity Secures $40M for Cardiac AI

Implicity has secured $40M to expand its AI-supported remote cardiac monitoring platform across the US and Europe.

What happened

The company works with data generated by cardiac implantable electronic devices, helping care teams monitor patients remotely and prioritise alerts. The new financing is intended to support commercial expansion and further development of its software platform.

Why it matters

Remote cardiac monitoring creates large volumes of alerts and device data that clinicians must review. The challenge is not simply collecting that information, but identifying which signals require attention. AI can help triage events, reduce unnecessary workload and make monitoring programmes easier to scale across larger patient populations.

The bigger picture

Some of the most credible healthcare AI businesses are being built around narrow, regulated workflows where the economic and clinical value can be measured. Cardiac monitoring fits that pattern: software augments specialist teams rather than trying to automate medicine broadly.